Article Detail - JF Part B
Self-Administered Drug Exclusion List (A53033) - R47 - Effective October 15, 2021
Date Posted: May 21, 2026
This billing and coding article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).
Effective Date: October 15, 2021
Summary of Changes:
Under Excluded CPT/HCPCS Codes, added J3357, Stelara® subcutaneous, back to the SAD listing as it was removed in error with the previous revision.
Visit the Self-Administered Drugs (SADs) webpage to view the Self-Administered Drug Exclusion List.
To view the complete listing of billing and coding articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Billing and Coding Articles webpage.